Literature DB >> 12113552

The role of LFA-1 in osteoclast development induced by co-cultures of mouse bone marrow cells and MC3T3-G2/PA6 cells.

N Tani-Ishii1, J M Penninger, G Matsumoto, T Teranaka, T Umemoto.   

Abstract

Interactions between leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) influence the development of osteoclasts. However, little is known about how these adhesion molecules are involved in the process of osteoclast development. This study evaluated the role of LFA-1 and its ligands in osteoclast development and bone resorption. Co-cultures of bone marrow cells from LFA-1-deficient mice and MC3T3-G2/PA6 (PA6) cells were cultured in the presence of 1alpha,25(OH)2D3 and dexamethasone for 7 days. The number of TRAP-positive cells that were generated by bone marrow cells from LFA-1-deficient mice was smaller than that generated by bone marrow cells from wild-type mice. In addition, the bone-resorbing activity of osteoclast-like cells that were generated from LFA-1-deficient mice was lower than that generated by osteoclast-like cells from wild-type mice. Immunofluorescence flow cytometry showed that osteoclast stromal PA6 cells expressed the cell adhesion molecules, ICAM-1 and VCAM-1. When monoclonal antibodies to mice VCAM-1, CD11b or CD18 were added separately to the co-culture system, the number of TRAP-positive cells that were generated from LFA-1-deficient mice was 20-30% smaller than that generated from wild-type mice. The formation of TRAP-positive cells from both LFA-1 deficient and wild-type mice was especially inhibited by anti-CD18 antibody, in comparison to the addition of normal IgG serum. These results suggest that LFA-1 adhesion molecules play a role in osteoclast development by affecting adhesion between stromal cells and osteoclast progenitors before the occurrence of ODF-ODF receptor signaling. CD18 appears to be a key adhesion molecule in cell-to-cell contacts during the early stage of osteoclast development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113552     DOI: 10.1034/j.1600-0765.2002.00610.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  8 in total

Review 1.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

2.  Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis.

Authors:  Yasuo Miura; Masako Miura; Stan Gronthos; Matthew R Allen; Chunzhang Cao; Thomas E Uveges; Yanming Bi; Driss Ehirchiou; Angela Kortesidis; Songtao Shi; Li Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

3.  Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.

Authors:  Veronica Garcia-Palacios; Ho Yeon Chung; Sun Jin Choi; Aliye Sarmasik; Noriyoshi Kurihara; Jun Won Lee; Deborah L Galson; Robert Collins; G David Roodman
Journal:  Bone       Date:  2006-09-25       Impact factor: 4.398

4.  An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro.

Authors:  Julio C Fernandes; Qin Shi; Mohamed Benderdour; Daniel Lajeunesse; Patrick Lavigne
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

5.  Chip-based comparison of the osteogenesis of human bone marrow- and adipose tissue-derived mesenchymal stem cells under mechanical stimulation.

Authors:  Sang-Hyug Park; Woo Young Sim; Byoung-Hyun Min; Sang Sik Yang; Ali Khademhosseini; David L Kaplan
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

6.  Porphyromonas gulae 41-kDa fimbriae induced osteoclast differentiation and cytokine production.

Authors:  Haruka Sasaki; Kiyoko Watanabe; Toshizo Toyama; Yasunori Koyata; Nobushiro Hamada
Journal:  J Vet Med Sci       Date:  2014-11-25       Impact factor: 1.267

7.  NDRG2 Expression Decreases Tumor-Induced Osteoclast Differentiation by Down-regulating ICAM1 in Breast Cancer Cells.

Authors:  Bomi Kim; Sorim Nam; Ji Hyun Lim; Jong-Seok Lim
Journal:  Biomol Ther (Seoul)       Date:  2016-01-01       Impact factor: 4.634

8.  Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling.

Authors:  Blair Hopwood; Anna Tsykin; David M Findlay; Nicola L Fazzalari
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.